Comparison of outcomes after donor lymphocyte infusion with or without prior chemotherapy for minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Comparison of outcomes after donor lymphocyte infusion with or without prior chemotherapy for minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation

Published:2017-03-11 Issue:5 Volume:96 Page:829-838
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Mo Xiao-Dong,Zhang Xiao-Hui,Xu Lan-Ping,Wang Yu,Yan Chen-Hua,Chen Huan,Chen Yu-Hong,Han Wei,Wang Feng-Rong,Wang Jing-Zhi,Liu Kai-Yan,Huang Xiao-Jun

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-017-2960-7.pdf

Reference43 articles.

1. Muñoz A, Badell I, Olivé T et al (2002) Second allogeneic hematopoietic stem cell transplantation in hematologic malignancies in children: long-term results of a multicenter study of the Spanish Working Party for Bone Marrow Transplantation in Children (GETMON). Haematologica 87:331–332

2. Bader P, Kreyenberg H, Hoelle W et al (2004) Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy? J Clin Oncol 22:1696–1705

3. Horn B, Petrovic A, Wahlstrom J et al (2015) Chimerism-based pre-emptive immunotherapy with fast withdrawal of immunosuppression and donor lymphocyte infusions after allogeneic stem cell transplantation for pediatric hematologic malignancies. Biol Blood Marrow Transplant 21:729–737

4. Rettinger E, Willasch AM, Kreyenberg H et al (2011) Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation. Blood 118:5681–5688

5. Pulsipher MA (2014) Chimerism versus minimal residual disease monitoring after allogeneic transplantation—when do we act and will intervention improve outcomes? Biol Blood Marrow Transplant 20:1461–1462

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Donor Lymphocyte Infusion for Relapsed Acute Leukemia or Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation: A Single-Institute Retrospective Analysis;Internal Medicine;2024-01-15

2. Long-Term Remission Achieved by Modified Donor Lymphocyte Infusion Combined with Chemotherapy and Azacitidine Maintenance Therapy in a Patient with Recurrence after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review;Advances in Clinical Medicine;2024

3. The delicate balance of graft versus leukemia and graft versus host disease after allogeneic hematopoietic stem cell transplantation;Expert Review of Hematology;2023-11-06

4. Prophylactic versus Preemptive modified donor lymphocyte infusion for high-risk acute leukemia after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study;Bone Marrow Transplantation;2023-10-31

5. Outcomes of haploidentical haematopoietic stem cell transplantation for adolescent and young adults with acute myeloid leukaemia;British Journal of Haematology;2023-06-26